Background Chronic bronchitis (CB) is strongly associated with cigarette smoking, but not all smokers develop CB. We aimed to evaluate whether measures of structural airway disease on CT are ...

Background Antimicrobial resistance (AMR) is a growing global health crisis and is particularly relevant to people living ...

Background: Haemophilus influenzae is the causative agent of multiple human disease conditions among multiple sites in the human body. Underlying genetic mechanisms are elusive, particularly in ...

Lyme infection-associated chronic illnesses (IACI) share symptoms common to other IACI such as Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. Despite the chronic impact on the ...

The respiratory fluoroquinolones include levofloxacin, moxifloxacin and gemifloxacin and have been recommended as a first-line treatment for AECB in patients who have chronic bronchitis ...

Since the obstruction represents excess mucus in the tracheobronchial tree, the abnormality is best regarded as chronic bronchitis; however, this is not the usual concept of bronchitis.

Chronic obstructive pulmonary disease (COPD) refers to a group of lung diseases, including chronic bronchitis and emphysema, and cannot be cured.

Conclusion Chronic bronchitis is a critical component in the syndrome of COPD. Elderly patients are at increased risk for both exacerbations of CB and AECB.

Nontypeable Haemophilus influenzae (NTHi) is a leading cause of respiratory tract infections worldwide and continues to be a global health burden. Adhesion and colonization of host cells are crucial ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic ...